a public good project by the
Synthesis
Company
of California

© 2026

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature | doi.page

0 citations0 references

Google Scholar doi.org

18F-fluorocholine for prostate cancer imaging: a systematic review of the literature

Prostate Cancer and Prostatic Diseases·2011·Vol. 15(1), pp. 45–55

Citations Over TimeTop 1% of 2011 papers

Glenn Bauman, Tarik Belhocine, Michael S. Kovacs, Aaron D. Ward, Mohsen Beheshti, Irina Rachinsky

Related Papers

→ Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging of the Adenosine A_2A Receptor System Using Positron Emission Tomography(2000)95 cited
→ No significant impact of prior treatment profile with docetaxel on the efficacy of cabazitaxel in Japanese patients with metastatic castration-resistant prostate cancer(2017)14 cited
→ Safety and Efficacy of Cabazitaxel in the Docetaxel-Treated Patients with Hormone-Refractory Prostate Cancer(2012)19 cited
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography(2000)
→ Pros and cons of docetaxel used to treat metastatic hormone-sensitive prostate cancer: The cons(2016)